Orthofix Medical saw no growth in patent filings in April and highest growth of 1.99% in grants in May in Q2 2024. Compared to Q1 2024, Q2 2024 saw no growth in patent filings and no change in grants. GlobalData’s DataBook provides a comprehensive analysis of Orthofix Medical’s patent filings and grants. Buy the databook here.
Orthofix Medical has been focused on protecting inventions in European Patent Office(EPO) with eight publications in Q2 2024
The European Patent Office(EPO) Patent Office dominates the patent filings and grants with nearly 50% filings and 40% grants. The European Patent Office(EPO), United States(US), Spain(ES), and Japan(JP) patent Office are among the top ten patent offices where Orthofix Medical is filings its patents. Among the top granted patent authorities, Orthofix Medical has 40% of its grants in European Patent Office(EPO), 20% in Spain(ES) and 20% in Japan(JP).
Johnson & Johnson could be the strongest competitor for Orthofix Medical
In terms of grant share, Orthofix Medical stands in fifth position among its competitors. Orthofix Medical and Johnson & Johnson secured the top positions according to recent patent publication data.
Patents related to healthtech and connected care lead Orthofix Medical's portfolio
Orthofix Medical has the highest number of patents in healthtech followed by, connected care and remote patient monitoring. For healthtech, nearly 25% of patents were filed and no patents were granted in Q2 2024.
Orthopedic devices related patents lead Orthofix Medical portfolio followed by general surgery devices, and healthcare it
Orthofix Medical has highest number of patents in orthopedic devices followed by general surgery devices, healthcare it, image management. For orthopedic devices, nearly 80% of patents were filed and 60% of patents were granted in Q2 2024.
For comprehensive analysis of Orthofix Medical's filings and grants, buy the databook here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.